| Ticker: | TELA |
| Current Price: | $0.82 |
| % Daily Change: | -4.64% |
| Volume (1,000s): | 129.18 |
| Average Volume (1,000s): | 151.07 |
| Market Cap (M): | $37.06 |
| 1/2/2024 Price: | $6.62 |
| Change Since Inception: | -87.61% |
1 Great Valley Parkway
Suite 24
Malvern, PA 19355
United States
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.